Tahir Latif

Tahir Latif

University of Cincinnati - Cincinnati / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1773464
person_outline Tahir Latif's MOST POPULAR ARTICLES
1-) Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomibS Jagannathan, MAY Abdel-Malek, E Malek, N Vad, T Latif, KC Anderson, ...Leukemia 29 (11), 2184-2191, 2015982015
2-) Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemiaM Kesarwani, Z Kincaid, A Gomaa, E Huber, S Rohrabaugh, Z Siddiqui, ...Nature medicine 23 (4), 472-482, 2017972017
3-) Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV)(JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)T Latif, L Wood, C Connell, DC Smith, D Vaughn, D Lebwohl, ...Investigational new drugs 23, 79-84, 2005962005
4-) COVID-19 vaccination and breakthrough infections in patients with cancerAL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ...Annals of Oncology 33 (3), 340-346, 2022952022
5-) Pattern of marginal local failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy for resectable and borderline resectable pancreas cancerJ Kharofa, M Mierzwa, O Olowokure, J Sussman, T Latif, A Gupta, C Xie, ...American Journal of Clinical Oncology 42 (3), 247-252, 2019782019